v3.25.0.1
Unaudited Condensed Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Sep. 30, 2024
Assets    
Cash, cash equivalents, and restricted cash $ 26,607,002 $ 24,916,285
Prepaid expenses and other current assets 1,773,134 1,547,928
Current assets of discontinued operations 0 8,759,011
Total current assets 28,380,136 35,223,224
Property and equipment, net 452,043 481,372
Operating lease right-of-use assets 3,127,887 3,250,623
Goodwill 6,878,932 6,878,932
Other assets 989,596 989,596
Long-term assets of discontinued operations 0 13,595,025
Total assets 39,828,594 60,418,772
Liabilities and Stockholders' Equity    
Accounts payable 1,994,645 2,259,668
Accrued research and development costs 1,572,429 120,448
Accrued compensation 1,503,233 4,494,278
Accrued expenses and other current liabilities 535,472 549,237
Residual royalty agreement liability, short-term portion 0 1,025,837
Operating lease liability, short-term portion 742,449 736,970
Current liabilities of discontinued operations 0 2,681,530
Total current liabilities 6,348,228 11,867,968
Residual royalty agreement liability, long-term portion 0 8,850,792
Operating lease liability, long-term portion 2,775,190 2,905,309
Other liabilities 4,078,187 4,461,920
Long-term liabilities of discontinued operations 0 16,071
Total liabilities 13,201,605 28,102,060
Commitments and contingencies (Note 12)
Stockholders' equity:    
Preferred stock; no shares issued and outstanding at December 31, 2024 and September 30, 2024 0 0
Common stock, par value $0.01 per share; 308,000,000 shares authorized, 148,567,624 issued and 146,383,920 shares outstanding at December 31, 2024 and September 30, 2024 1,485,676 1,485,676
Additional paid-in-capital 336,462,900 333,788,795
Accumulated other comprehensive loss 0 (581,519)
Accumulated deficit (303,514,982) (294,569,635)
Treasury stock, 2,183,704 shares, at cost (7,806,605) (7,806,605)
Total stockholders' equity 26,626,989 32,316,712
Total liabilities and stockholders' equity $ 39,828,594 $ 60,418,772

Source